Parkinson disease

You have access
Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz and Martijn L.T.M. Müller

Journal of Nuclear Medicine March 1, 2022, 63 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.121.261939
You have access
Dynamic ¹⁸F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session
Shichun Peng, Chris Tang, Katharina Schindlbeck, Yaacov Rydzinski, Vijay Dhawan, Phoebe G. Spetsieris, Yilong Ma and David Eidelberg

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1775-1782; DOI: https://doi.org/10.2967/jnumed.120.257345
You have access
Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
You have access
Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of ¹¹C-DTBZ PET Combined with Correlational Tractography
Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Fang-Cheng Yeh, Nicholas D’Cruz, Prabesh Kanel and Martijn L.T.M. Müller

Journal of Nuclear Medicine April 1, 2021, 62 (4) 545-552; DOI: https://doi.org/10.2967/jnumed.120.248500
You have access
Cerebral Metabolic Changes Related to Freezing of Gait in Parkinson Disease
Trina Mitchell, Alexandra Potvin-Desrochers, Anne-Louise Lafontaine, Oury Monchi, Alexander Thiel and Caroline Paquette

Journal of Nuclear Medicine May 1, 2019, 60 (5) 671-676; DOI: https://doi.org/10.2967/jnumed.118.218248
You have access
Noradrenergic Deficits in Parkinson Disease Imaged with ¹¹C-MeNER
Adjmal Nahimi, Michael Sommerauer, Martin B. Kinnerup, Karen Østergaard, Michael Wintherdahl, Jan Jacobsen, Anna Schacht, Birger Johnsen, Malene F. Damholdt, Per Borghammer and Albert Gjedde

Journal of Nuclear Medicine April 1, 2018, 59 (4) 659-664; DOI: https://doi.org/10.2967/jnumed.117.190975
You have access
¹⁸F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
Philipp T. Meyer, Lars Frings, Gerta Rücker and Sabine Hellwig

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1888-1898; DOI: https://doi.org/10.2967/jnumed.116.186403
You have access
Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Parkinsonian Syndrome with ¹⁸F-AV133 and PET
Paschal K. Alexander, Yenni Lie, Gareth Jones, Chomalaven Sivaratnam, Svetlana Bozinvski, Rachel S. Mulligan, Kenneth Young, Victor L. Villemagne and Christopher C. Rowe

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.116.189019
You have access
2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with ¹¹C-Hydroxyephedrine PET
Ka Kit Wong, David M. Raffel, Nicolaas I. Bohnen, Gulcin Altinok, Sid Gilman and Kirk A. Frey

Journal of Nuclear Medicine February 1, 2017, 58 (2) 326-331; DOI: https://doi.org/10.2967/jnumed.116.176891
You have access
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using ¹⁸F-FE-PE2I in Healthy Controls and Parkinson Disease Patients
Ida Sonni, Patrik Fazio, Martin Schain, Christer Halldin, Per Svenningsson, Lars Farde and Andrea Varrone

Journal of Nuclear Medicine October 1, 2016, 57 (10) 1529-1534; DOI: https://doi.org/10.2967/jnumed.115.171231

Main menu

User menu

Search

Parkinson disease

Pages